Next-generation sequencing (NGS) molecular analysis of the kidney tumor showed a type II EWSR1:FLI1 gene fusion between exon 7 of EWSR1 and exon 5 of FLI1 (Figure 3). The gene discussed is FLI1; the disease is kidney neoplasm.